Core Viewpoint - Traditional Chinese medicine (TCM) is being modernized and internationalized by Kang'er Biological Group through scientific research and development of herbal products, leveraging advanced technologies and high-quality raw materials [1][3][5]. Group 1: Company Overview - Kang'er Biological Group focuses on the global market by selecting high-quality traditional medicinal materials and developing a series of herbal brand raw materials based on modern medicine, nutrition, and traditional Chinese medicine [1]. - The company has established a production base in Gansu Longxi, covering 102 acres, with an investment of 246 million yuan to create a comprehensive processing complex for medicinal materials [1]. - Kang'er Biological has developed over 20 plant brand raw materials, including 12 compound TCM raw materials, and has received FDA approval for 7 compound TCM products with 92 health functions [3]. Group 2: Technological Advantages - The company has mastered three major TCM technology advantages: herbal fermentation technology, protein engineering technology, and active small molecule technology [3]. - Herbal fermentation technology enhances the extraction and conversion of effective components from medicinal materials, increasing therapeutic efficacy [3]. - Protein engineering technology utilizes advanced enzymatic processes to break down large proteins into small peptides, improving digestibility [3]. - Active small molecule technology allows for the precise cutting of active substances into smaller fragments while retaining their biological activity and effectiveness [3]. Group 3: Product Development and Safety - Kang'er Biological has conducted multiple preclinical evaluations to ensure product efficacy and has performed toxicological safety tests in accordance with TCM and health food regulations [7]. - The company has initiated human clinical trials both domestically and internationally to further validate the effectiveness and safety of its products [7].